p159 pPr-luc Citations (8)

Originally described in: A single vector containing modified cre recombinase and LOX recombination sequences for inducible tissue-specific amplification of gene expression.
Kaczmarczyk SJ, Green JE Nucleic Acids Res 2001 Jun 15;29(12):E56-6. PubMed Journal

---

Articles Citing p159 pPr-luc

Articles
Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development. Sheppard RL, Spangenburg EE, Chin ER, Roth SM. Physiol Genomics. 2011 Oct 20;43(20):1135-43. doi: 10.1152/physiolgenomics.00049.2011. Epub 2011 Aug 9. PubMed
Androgen receptor serine 81 mediates Pin1 interaction and activity. La Montagna R, Caligiuri I, Maranta P, Lucchetti C, Esposito L, Paggi MG, Toffoli G, Rizzolio F, Giordano A. Cell Cycle. 2012 Sep 15;11(18):3415-20. doi: 10.4161/cc.21730. Epub 2012 Aug 16. PubMed
Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression. Lin Y, Lu Z, Kokontis J, Xiang J. Biochem Biophys Res Commun. 2013 Jan 4;430(1):289-93. doi: 10.1016/j.bbrc.2012.10.135. Epub 2012 Nov 15. PubMed
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, Phal PM, Kurganovs N, Chin X, Kerger M, Warren AY, Neal D, Gnanapragasam V, Rosenfeld N, Pedersen JS, Ryan A, Haviv I, Costello AJ, Corcoran NM, Hovens CM. Nat Commun. 2015 Apr 1;6:6605. doi: 10.1038/ncomms7605. PubMed
Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer. Kato Y, Ochiai K, Michishita M, Azakami D, Nakahira R, Morimatsu M, Ishiguro-Oonuma T, Yoshikawa Y, Kobayashi M, Bonkobara M, Kobayashi M, Takahashi K, Watanabe M, Omi T. Vet J. 2015 Nov;206(2):143-8. doi: 10.1016/j.tvjl.2015.08.002. Epub 2015 Aug 7. PubMed
Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity. Ochiai K, Morimatsu M, Kato Y, Ishiguro-Oonuma T, Udagawa C, Rungsuriyawiboon O, Azakami D, Michishita M, Ariyoshi Y, Ueki H, Nasu Y, Kumon H, Watanabe M, Omi T. Oncotarget. 2016 Jan 19;7(3):3283-96. doi: 10.18632/oncotarget.6488. PubMed
The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein alpha. Azakami D, Nakahira R, Kato Y, Michishita M, Kobayashi M, Onozawa E, Bonkobara M, Kobayashi M, Takahashi K, Watanabe M, Ishioka K, Sako T, Ochiai K, Omi T. Vet Comp Oncol. 2016 Jan 14. doi: 10.1111/vco.12199. PubMed
Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines. Kato Y, Ochiai K, Kawakami S, Nakao N, Azakami D, Bonkobara M, Michishita M, Morimatsu M, Watanabe M, Omi T. BMC Vet Res. 2017 Jun 9;13(1):170. doi: 10.1186/s12917-017-1094-4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.